. 2022 May 6;14(5):1001. doi: 10.3390/pharmaceutics14051001
© 2022 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Scheme 6.
Synthesis of delgocitinib (route 2).